Contrave does produce meaningful weight loss, though the results are moderate compared to newer injectable medications. In clinical trials lasting 56 weeks, people taking Contrave lost about 6.1% of their body weight on average, compared to 1.3% in the placebo group. That difference is real, but it places Contrave in the middle of the pack among prescription weight loss options.
How Much Weight People Actually Lose
The most reliable data comes from the COR-I trial, a large, randomized, placebo-controlled study published in The Lancet. Participants taking the standard dose lost an average of 6.1% of their total body weight over 56 weeks. For someone weighing 220 pounds, that translates to roughly 13 pounds. The placebo group, which also received diet and exercise guidance, lost only about 3 pounds over the same period.
Not everyone responds equally. According to FDA-reviewed data, between 36% and 57% of people taking Contrave lost at least 5% of their body weight within a year, compared to 17% to 43% on placebo. That means a substantial portion of users don’t hit the 5% threshold that’s generally considered clinically meaningful. If you haven’t lost at least 5% of your starting weight by 12 weeks on the full dose, it’s unlikely the medication will produce significant results with continued use.
Longer-term real-world data paints a slightly different picture than the clinical trials. A two-year comparative analysis found that Contrave users achieved about 3.26% weight loss from baseline at 24 months, with some plateauing or slight rebound after the initial decrease. This suggests that maintaining results over time requires ongoing effort beyond the medication itself.
How Contrave Works in the Brain
Contrave combines two older medications that each affect different parts of the brain involved in eating behavior. One component works on the hypothalamus, the region that regulates hunger and metabolism. The other targets the brain’s reward system, the same circuitry involved in cravings and the pleasure response to food. Together, they address both the biological drive to eat and the emotional pull toward food.
This dual approach was designed around the understanding that obesity involves changes in both hunger regulation and reward-driven eating. Many people who struggle with weight aren’t just physically hungry. They experience strong cravings and compulsive eating patterns that a medication targeting only appetite wouldn’t fully address. By working on both systems simultaneously, Contrave can reduce how much you want to eat and how rewarding food feels when you do eat it.
How It Compares to Other Options
Contrave’s weight loss results are modest when stacked against the newer GLP-1 injectable medications that have dominated headlines. In a two-year comparative analysis, tirzepatide (the active ingredient in Zepbound) produced 6.23% weight loss, semaglutide (Wegovy) achieved 5.06%, and Contrave came in at 3.26%. Notably, tirzepatide and semaglutide maintained their weight loss throughout the study period, while Contrave showed a plateau or slight rebound after the initial decrease.
That said, Contrave has some practical advantages. It’s an oral pill rather than an injection, it’s been available as a generic (which can significantly lower cost), and it doesn’t carry the gastrointestinal side effects like persistent nausea and diarrhea that many GLP-1 users experience. For people who can’t tolerate injectables, can’t access them due to cost or supply issues, or prefer a pill, Contrave remains a reasonable option.
The Role of Diet and Exercise
Clinical trial participants didn’t just take a pill and wait. They were advised to cut about 500 calories per day from their diet and to exercise regularly. In some studies, participants in an intensive lifestyle arm received structured coaching calls, individualized goal setting, nutrition tracking tools, and ongoing support from dieticians. The weight loss numbers reported in trials reflect this combined approach, not the medication alone.
This is an important detail. Contrave is designed to make the behavioral changes easier by reducing hunger and cravings, but it won’t override a diet that stays the same. Think of it as a tool that lowers the difficulty level of eating less, not a replacement for doing so.
Side Effects and Tolerability
Nausea is the most common side effect and the most frequent reason people stop taking Contrave. Constipation, headache, vomiting, dizziness, trouble sleeping, dry mouth, and diarrhea also show up regularly. The gradual dose increase over the first four weeks is specifically designed to minimize these effects. You start with one tablet per day in week one, add a second in week two, a third in week three, and reach the full dose of four tablets daily (two in the morning, two in the evening) by week four.
For most people, nausea improves after the first few weeks as the body adjusts. Taking the medication with food can help. If nausea remains severe at any point during the titration, it’s worth discussing the timeline with your prescriber rather than pushing through or stopping abruptly.
Who Should Not Take Contrave
Contrave carries several strict contraindications that aren’t just precautionary. Because one of its components is an opioid blocker, anyone currently taking opioid painkillers, on opioid replacement therapy, or in opioid withdrawal cannot take it. Doing so can trigger sudden, severe withdrawal symptoms. People need to be completely off short-acting opioids for at least 7 to 10 days before starting, and those coming off longer-acting opioids like methadone or buprenorphine may need two full weeks.
The medication is also off-limits for people with a seizure disorder, since one of its components lowers the seizure threshold. Other contraindications include a history of bulimia or anorexia nervosa, bipolar disorder, uncontrolled high blood pressure, and concurrent use of certain antidepressants called MAO inhibitors. People going through alcohol or benzodiazepine withdrawal are also at increased seizure risk and cannot use this medication.
Contrave also carries a boxed warning (the FDA’s most serious label warning) related to suicidal thoughts and behavior, because one of its ingredients belongs to a class of medications associated with this risk, particularly in younger adults. This doesn’t mean the medication commonly causes these effects, but it does mean you should be aware of mood changes, especially in the first few months.
Setting Realistic Expectations
Contrave works, but it works modestly. If you’re expecting the dramatic 15% to 20% body weight reductions seen with the newest injectable medications, Contrave won’t deliver that. What it can do is help you lose a meaningful amount of weight, particularly if strong cravings and reward-driven eating are a big part of why you struggle with weight management. A 5% to 6% reduction in body weight is enough to improve blood pressure, blood sugar, cholesterol, and other metabolic markers, even if it doesn’t feel transformative on the scale.
The 12-week mark is a useful checkpoint. If the medication is going to work for you, you’ll typically see clear progress by then. If the scale hasn’t moved meaningfully by that point on the full dose, continuing is unlikely to change the outcome.